论文部分内容阅读
目的:观察妇产科米非司酮配伍米索前列醇用于孕10～14周钳刮术临床疗效。方法:选取我院54例孕10～14周的孕妇要进行终止妊娠采用钳刮术作为观察组,并对其同时进行米非司酮配伍米索前列醇的药物治疗,在选取同期同类孕妇仅采用常规钳刮术治疗作为对照组,对比观察两组患者的临床疗效及疗效的一般情况。结果:观察组有效率为96.3%,对照组总有效率为61.1%,两组差异明显,具有临床意义;观察组的手术时间、出血量及疼痛指数均明显优于对照组,差异明显具有临床意义。结论:在妇产科疾病中使用米非司酮配伍米索前列醇作为孕10～14周钳刮术前治疗对终止妊娠具有较好疗效,且术中疼痛少,手术时间短、出血量小等特点,值得临床应用。
Objective: To observe the clinical efficacy of mifepristone and misoprostol in obstetrics and gynecology for pliersurgical curettage between 10 and 14 weeks. Methods: 54 pregnant women in our hospital from 10 to 14 weeks pregnant women to be terminated pregnancy using forceps curettage as observation group, and its simultaneous mifepristone with misoprostol drug treatment, select the same period only pregnant women The use of conventional forceps curettage as a control group, compared the two groups of patients to observe the clinical efficacy and efficacy of the general situation. Results: The effective rate was 96.3% in the observation group and 61.1% in the control group, with significant difference between the two groups, which had clinical significance. The operation time, bleeding volume and pain index of the observation group were significantly better than those of the control group significance. Conclusion: The use of mifepristone and misoprostol in obstetrics and gynecology is effective in terminating pregnancy after 10 to 14 weeks of clamp curettage, with less intraoperative pain, shorter operative time and less bleeding And other characteristics, it is worth clinical application.